BULIS VERONICA SANCHEZ (VP, Corporate Controller) sold 22.5% of their position (2.07K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $74.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/6/2026ACC: 0002095702-26-000001
Officer· VP, Corporate Controller
Since Feb 2026
-2.07K
Net shares
Net seller
$74.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.07K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.14K
Price / share
$38.67
Trade value
$43.93K
% of position
12.3%
12/24/2025
9.21K→8.08K
Common Stock
Direct
Shares
−936.00
Price / share
$32.32
Trade value
$30.25K
% of position
11.6%
12/30/2025
8.08K→7.14K
Total
Net shares
−2.07K
Net value
-$74.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/24/2025 | S · Sale | −1.14K | $38.67 | $43.93K | 12.3% | 9.21K | 8.08K |
| Common Stock Direct | 12/30/2025 | S · Sale | −936.00 | $32.32 | $30.25K | 11.6% | 8.08K | 7.14K |
| Total | −2.07K | -$74.18K | ||||||
Derivative Transactions0
No derivative transactions reported